XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
62 hedge funds and large institutions have $527M invested in Acceleron Pharma in 2013 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
62
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$83.9M | |
| 2 | +$71.4M | |
| 3 | +$39.4M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$30.3M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$23.6M |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$835K | |
| 3 | -$445K | |
| 4 |
FSA
Franklin Street Advisors
Chapel Hill,
North Carolina
|
-$71.3K |
| 5 |
SSG
Summit Securities Group
New York
|
-$1K |